The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ACHILLION PHARMACEUTICALS INC COM 00448Q201 16,019 3,490,077 SH   DFND 1 0 3,490,077 0
ADURO BIOTECH INC COM 00739L101 3,420 300,000 SH   DFND 1 0 300,000 0
ANAPTYSBIO INC COM 032724106 39,705 1,659,200 SH   DFND 1 0 1,659,200 0
ANTHERA PHARMACEUTICALS INC COM 03674U300 1,631 1,006,507 SH   DFND 1 0 1,006,507 0
ARQULE INC COM 04269E107 9,176 7,400,128 SH   DFND 1 0 7,400,128 0
ARRAY BIOPHARMA INC COM 04269X105 50,719 6,059,625 SH   DFND 1 0 6,059,625 0
BIOLINERX LTD SPONSORED ADR 09071M106 14,875 17,500,000 SH   DFND 1 0 17,500,000 0
BLUEPRINT MEDICINES CORP COM 09627Y109 80,649 1,591,646 SH   DFND 1 0 1,591,646 0
CASCADIAN THERAPEUTICS INC COM NEW 14740B606 11,640 3,133,224 SH   DFND 1 0 3,133,224 0
CHEMOCENTRYX INC COM 16383L106 77,205 8,248,416 SH   DFND 1 0 8,248,416 0
CONCERT PHARMACEUTICALS INC COM 206022105 25,904 1,856,895 SH   DFND 1 0 1,856,895 0
CORVUS PHARMACEUTICALS INC COM 221015100 3,318 274,196 SH   DFND 1 0 274,196 0
CTI BIOPHARMA CORP COM NEW 12648L601 28,454 8,596,357 SH   DFND 1 0 8,596,357 0
CYTOKINETICS INC COM NEW 23282W605 24,083 1,990,321 SH   DFND 1 0 1,990,321 0
CYTOMX THERAPEUTICS INC COM 23284F105 31,418 2,026,998 SH   DFND 1 0 2,026,998 0
FATE THERAPEUTICS INC COM 31189P102 1,268 391,386 SH   DFND 1 0 391,386 0
FORWARD PHARMA A/S SPONSORED ADR 34986J105 28,215 1,387,853 SH   DFND 1 0 1,387,853 0
GLYCOMIMETICS INC COM 38000Q102 33,147 2,970,182 SH   DFND 1 0 2,970,182 0
GTX INC DEL COM NEW 40052B207 5,864 1,108,433 SH   DFND 1 0 1,108,433 0
IGNYTA INC COM 451731103 7,245 700,000 SH   DFND 1 0 700,000 0
INFINITY PHARMACEUTICALS INC COM 45665G303 12,350 7,866,108 SH   DFND 1 0 7,866,108 0
LOXO ONCOLOGY INC COM 548862101 37,159 463,386 SH   DFND 1 0 463,386 0
NIVALIS THERAPEUTICS INC COM 65481J109 6,374 2,644,806 SH   DFND 1 0 2,644,806 0
ONCOMED PHARMACEUTICALS INC COM 68234X102 14,653 4,400,289 SH   DFND 1 0 4,400,289 0
OREXIGEN THERAPEUTICS INC COM NEW 686164302 2,131 734,976 SH   DFND 1 0 734,976 0
OREXIGEN THERAPEUTICS INC NOTE 2.750% 686164AB0 5,025 10,000,000 PRN   DFND 1 0 10,000,000 0
PAIN THERAPEUTICS INC COM NEW 69562K506 1,341 325,508 SH   DFND 1 0 325,508 0
PIERIS PHARMACEUTICALS INC COM 720795103 17,669 3,491,933 SH   DFND 1 0 3,491,933 0
REGULUS THERAPEUTICS INC COM 75915K101 3,232 3,278,900 SH   DFND 1 0 3,278,900 0
SPRING BK PHARMACEUTICALS INC COM 849431101 8,332 615,384 SH   DFND 1 0 615,384 0
SUNESIS PHARMACEUTICALS INC COM PAR 867328700 4,781 1,770,692 SH   DFND 1 0 1,770,692 0
TOCAGEN INC COM 888846102 15,387 1,279,078 SH   DFND 1 0 1,279,078 0
XENON PHARMACEUTICALS INC COM 98420N105 11,084 3,518,830 SH   DFND 1 0 3,518,830 0
XOMA CORP DEL COM NEW 98419J206 10,505 1,502,800 SH   DFND 1 0 1,502,800 0